pharmaphorum
APRIL 6, 2021
From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.
Druggist
APRIL 6, 2021
Lacri-lube has been out of stock for months. Still, after all this time, some patients get repeat prescriptions issued with Laci-Lube on it. Patients who have Lacri-Lube eye ointment on their ‘repeats’ should contact their surgery and ask to remove it and replace it with Lacri-lube alternative eye ointments. I will list in this post the best Lacri-Lube alternative eye ointments and gels.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
APRIL 8, 2021
The collaboration will enable Charles River clients to access Valenceâs artificial intelligence platform in their pharmaceutical development projects.
Pharma Marketing Network
APRIL 9, 2021
This content is password protected. To view it please enter your password below: Password: The post Protected: Digital TV: A Boon for Pharma Marketers appeared first on Pharma Marketing Network.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
APRIL 8, 2021
A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.
Druggist
APRIL 3, 2021
Diltiazem cream (diltiazem hydrochloride cream) is a medicine prescribed in the UK to manage chronic anal fissure. Today I will answer the most common questions surrounding the use, availability and treatment with this cream. Summary: What is diltiazem cream used for? How does diltiazem help with anal fissures? Classification of anal fissures. The legal classification of topical diltiazem .
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Mirror
APRIL 9, 2021
Isolation gowns are essential equipment for infection-control strategies. They are the second most used PPE items after gloves. They were originally designed for health workers but can also be worn by random people to protect them from infections when they come in contact with infected people or substances. The different types of isolation gowns There are two major types of isolation gowns made for healthcare purposes: Surgical gowns: A surgical gown is a personal protective garment that is used
pharmaphorum
APRIL 9, 2021
The FDA says it has uncovered “deficiencies” in the marketing application for Provention Bio’s much-anticipated drug teplizumab for the prevention of type 1 diabetes (T1D) that could delay its review. The issues are holding up discussions between the agency and company about labeling and post-marketing requirements for teplizumab, and are concentrated around the pharmacokinetics data for the antibody, and whether it is comparable to the drug that its original developer Eli Lill
Druggist
APRIL 4, 2021
A new pharmacy service was recently launched in England, which allows the public to collect free COVID-19 lateral flow tests (lateral flow devices – LFDs) from community pharmacies. The NHS Community Pharmacy COVID -19 Lateral Flow Device (LFD) Distribution Service was launched on the 29th of March 2021, but the promotion of this service to the public will not start after Easter.
Outsourcing Pharma
APRIL 7, 2021
Especially with the COVID-19 pandemic impacting studies, the company says, putting patients at the center of studies and trial tech must be top priority.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Birth Control Pharmacist
APRIL 8, 2021
Free 22-page report describing the current landscape of direct pharmacy access to contraception in pharmacies, state policy approaches and experiences, as well as implementation. The 2020 report includes information for policy efforts in 2020, along with emphasis on definitions of reimbursement vs. payment and a new appendix with model bill elements. .
pharmaphorum
APRIL 8, 2021
COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . The 2021 WIRED Health conference took a broad view of the current pandemic situation, with speakers ranging from geneticists to intensive care doctors.
Lifewell Rx Pharmacy
APRIL 7, 2021
Most of us go to the pharmacy to get our prescriptions, an occasional treat, or a toiletry item. But did you know that they can do so much more for you? As the community’s leading independent pharmacy in Louisville, Kentucky , at LIFEWELL RX PHARMACY here are some of the services from your pharmacy that you may be missing out on: Pharmacy consultations.
Outsourcing Pharma
APRIL 8, 2021
The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Colors Make me Happy
APRIL 6, 2021
The COVID19 pandemic has amplified work-life challenges for many work-from-home employees as boundaries between work and home life become blurred. In these difficult times, the reality is that we need to make a living, but also need to make sure that we are still “living” to avoid becoming burned out. To address these new challenges, many companies have focused on employee well-being and have associated a work-life imbalance with excessive work demands.
pharmaphorum
APRIL 8, 2021
Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pay off, as the drug has now been approved by the FDA for triple-negative breast cancer. . Trodelvy (sacituzumab govitecan) was granted accelerated approval by the FDA in April last year, and is now indicated for adults with triple-negative breast cancer who have received at least two previous therapies for metastatic disease.
Mission-Driven Marketing Blog
APRIL 5, 2021
Inbound Marketing, a methodology which seeks to attract leads through generating valuable content and experiences, has been outpacing traditional forms of marketing, like Outbound Marketing or ‘Push’ Marketing, in recent years. Inbound Marketing solves the problem of contacts being overwhelmed and oversaturated with marketing and sales messaging and builds longer-lasting, mutually-beneficial relationships.
Outsourcing Pharma
APRIL 7, 2021
A leader from the global CRO discusses how putting the patient first in clinical research is essential to discovering new therapies for orphan diseases.
Colors Make me Happy
APRIL 3, 2021
The term “co-dependency” was initially coined by Alcoholics Anonymous in 1950 to describe those individuals whose unhealthy choices enable and encourage their partner with addiction. While this is still true, co-dependency more recently has a much broader definition. Although it is not recognized as a clinical diagnosis or a personality disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM), co-dependency is an unhealthy and potentially toxic relational dynamic.
pharmaphorum
APRIL 6, 2021
People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according to vaccines minister Nadhim Zahawi. The roll-out of the third coronavirus shot will come as the UK exits its second lockdown round, and in time to offset an anticipated dip in supply of the Oxford University/AstraZeneca AZD1222 vaccine in the coming weeks.
Med Ed 101
APRIL 7, 2021
We blogged about doxepin a few weeks ago now and I had a colleague bring this article to my attention. The relationship between doxepin and CYP2D6 is a very important one and I wanted to discuss it further with some potential drug interactions that may come up in practice. Here’s the abstract from the article. […]. The post Doxepin and CYP2D6 appeared first on Med Ed 101.
Outsourcing Pharma
APRIL 7, 2021
A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, fatal disease.
Pharma Marketing Network
APRIL 7, 2021
Native advertising may mean something different to you depending on what part of the industry you’re in whether it be in advertising or publishing. . Tune in and listen to the Pharma Marketing Network and fellow thought leaders from, ROI Marketplace, MedThink, and Sharecare.com, discuss their learnings and insights on native advertising from each of their respective vantage points – pharma-marketer, publisher, and agency. .
pharmaphorum
APRIL 7, 2021
Jan van de Winkel has overseen one of biotech’s big success stories since he took over Genmab’s CEO in 2010. He spoke to pharmaphorum’s news editor Richard Staines to outline his plans to create a European biotech powerhouse. . The last ten years has seen Denmark’s Genmab become one of biotech’s big success stories. Under the leadership of CEO Jan van de Winkel it has gone from financially precarious position following the stock market crash in the late noughties, to the darling of the Nasdaq wi
Med Ed 101
APRIL 4, 2021
Amiodarone is an older antiarrhythmic drug that you may see used in primary care and geriatrics. I’m well into my latest project on a NEW BOOK involving the prescribing cascade and polypharmacy. I wanted to share a part of it by discussing amiodarone adverse effects. Amiodarone adverse effects include things like ocular toxicity, QTc prolongation, […].
Outsourcing Pharma
APRIL 5, 2021
The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.
Pharma Times
APRIL 7, 2021
The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births
pharmaphorum
APRIL 7, 2021
Genmab’s CEO Jan van de Winkel has said he would consider spinning out a smaller autoimmune diseases biotech, while ruling out any interest in a merger with big pharma. . In an interview with pharmaphorum, van de Winkel noted that the company’s drugs could be used for diseases outside of cancer, where Copenhagen-based Genmab first made its mark. A drug it originally developed to treat leukaemia has been repurposed by Novartis as a treatment for multiple sclerosis.
The Infectious Pharmacist
APRIL 6, 2021
Photo by asim alnamat on Pexels.com. A friend of mine says that every news report should come with a warning similar to that for cigarettes: “Warning, this news report contains information that is both addictive and will be harmful to your mental health.” I think the same could be said for announcements by public health professionals. Listen, I get it, public health officials have to thread a very narrow needle.
Outsourcing Pharma
APRIL 5, 2021
The free Patient-Centric Trial Development Toolkit is aimed toward helping sites and sponsors identify and minimize risks in rare-disease clinical studies.
Pharma Times
APRIL 6, 2021
NHS England is rolling out Roche's new combined treatment Phesgo, which drastically cuts administration time
pharmaphorum
APRIL 9, 2021
UK artificial intelligence specialist Healx has begun a partnership with two medical charities that aims to uncover new therapies for the neurodegenerative disease Friedreich’s ataxia (FA). . Healx has joined forces with Ataxia UK and the US-based Friedreich’s Ataxia Research Alliance (FARA) on the project, and will use its AI-powered drug discovery platform Healnet to try to find already used drugs that could be repurposed as treatments for FA.
pharmaphorum
APRIL 9, 2021
Merck & Co has announced interim data from its pivotal Phase 3 KEYNOTE-564 trial evaluating immunotherapy Keytruda for the potential adjuvant treatment of patients with renal cell carcinoma (RCC) following surgery. . The interim analysis carried out by an independent data monitoring committee, revealed Keytruda showed a statistically significant and clinically meaningfully improvement in disease free survival compared with placebo.
pharmaphorum
APRIL 9, 2021
Eli Lilly’s JAK inhibitor Olumiant has missed its main objective in a phase 3 trial in hospitalised COVID-19 patients, but had a significant effect on mortality, a secondary endpoint. . The perplexing data showed that patients treated with Olumiant (baricitinib) were 2.7% less likely to progress to needing a ventilator or death compared to a placebo group, which wasn’t a statistically significant difference.
Expert insights. Personalized for you.
132 
Let's personalize your content